<DOC>
	<DOCNO>NCT00959738</DOCNO>
	<brief_summary>Diverting ileostomy create protect rectal anastomosis situation risk intestinal perforation . Currently , application rod hinder slippage loop establish technique perform divert loop ileostomy . However , various `` rod-less '' technique describe perform similar success . The aim study determine , whether modification ( without rod ) current standard method protective loop ileostomy formation ( rod ) could improve ileostomy specific morbidity . Secondary endpoint include stoma care , determinant quality life stoma function .</brief_summary>
	<brief_title>Diverting Loop Ileostomy : With Without Rod</brief_title>
	<detailed_description>Background For rectal anastomosis within 6 cm anal verge , leakage rate 15 % . Here liberal use protective stoma widely accept . Fecal diversion loop ostomy may also perform extended adhesiolysis serosal lesion risk intestinal perforation , patient obstruct rectal tumour require neoadjuvant radio-chemotherapy patient complex anorectal injury fistulas . Generally , divert loop ileostomy secure skin level mean support device order prevent retraction loop ileostomy abdomen . Nevertheless , due support rod , difficulty may occur apply stoma bag correctly leakage feces onto skin may occur even correct eversion afferent limb . Despite easy application stoma bag therefore reduce risk skin irritation , none alternative technique establish . In various non-randomized study rodless loop ileostomy describe overall morbidity 3 39 % . However definition morbidity varies significantly study randomise controlled trial miss far . Objective The aim study determine , whether modification ( without rod ) current standard method protective loop ileostomy formation ( rod ) could improve ileostomy specific morbidity . Secondary endpoint include stoma care , determinant quality life stoma function . Methods The study design multi-institutional , randomize control , two-armed study . Patients schedule protective loop ileostomy meeting eligibility criterion randomize creation loop ileostomy without sustain rod .</detailed_description>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<criteria>patient schedule planned protective loop ileostomy Exclusion Criteria patient longterm use corticosteroid ( &gt; 15 mg prednisolone equivalent ) immunosuppressive agent rapamune</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>loop ileostomy</keyword>
	<keyword>quality life</keyword>
	<keyword>morbidity</keyword>
	<keyword>Rectal Neoplasms</keyword>
</DOC>